QIAGEN N.V. Derivative, Collateral, Right to Reclaim Cash
QIAGEN N.V. (QGEN) had Derivative, Collateral, Right to Reclaim Cash of $22.53 million as of 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Notes › Offsetting
us-gaap:DerivativeCollateralRightToReclaimCash · last filed 2026-03-20
- 2025-12-31: Derivative, Collateral, Right to Reclaim Cash $22.53M.
- 2024-12-31: Derivative, Collateral, Right to Reclaim Cash $3.25M.
- 2023-12-31: Derivative, Collateral, Right to Reclaim Cash $87.67M.
- 2022-12-31: Derivative, Collateral, Right to Reclaim Cash $21.08M.
| Period end | Derivative, Collateral, Right to Reclaim Cash |
|---|---|
| 2025-12-31 | $22.53M 20-F · filed 2026-03-20 |
| 2024-12-31 | $3.25M 20-F · filed 2026-03-20 |
| 2023-12-31 | $87.67M 20-F · filed 2025-03-31 |
| 2022-12-31 | $21.08M 20-F · filed 2024-03-11 |
| 2021-12-31 | $11.20M 20-F · filed 2023-03-13 |
| 2020-12-31 | $56.10M 20-F · filed 2022-03-14 |
| 2019-12-31 | $2.68M 20-F · filed 2021-03-05 |
| 2018-12-31 | $25.37M 20-F · filed 2020-03-02 |
| 2017-12-31 | $21.91M 20-F · filed 2019-03-06 |
| 2016-12-31 | $1.20M 20-F · filed 2018-03-06 |